These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34418823)

  • 1. Evaluation of the Abbott Panbio
    Shaw JLV; Deslandes V; Smith J; Desjardins M
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bean Extract-Based Gargle for Efficient Diagnosis of Active COVID-19 Infection Using Rapid Antigen Tests.
    Kwon J; Ko E; Cho SY; Lee YH; Jun S; Lee K; Hwang E; Vaidya B; Hwang JH; Hwang JH; Kim N; Song MK; Kim HY; Ito D; Lin Y; Jo E; Yang KE; Chung HC; Cha S; Kim DI; Yi YS; Yun SH; Park SC; Lee S; Choi JS; Kim DS; Kim D
    Microbiol Spectr; 2022 Feb; 10(1):e0161421. PubMed ID: 35171037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
    Torres I; Poujois S; Albert E; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Apr; 27(4):636.e1-636.e4. PubMed ID: 33421573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.
    Jääskeläinen AE; Ahava MJ; Jokela P; Szirovicza L; Pohjala S; Vapalahti O; Lappalainen M; Hepojoki J; Kurkela S
    J Clin Virol; 2021 Apr; 137():104785. PubMed ID: 33711694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.
    Eleftheriou I; Dasoula F; Dimopoulou D; Lebessi E; Serafi E; Spyridis N; Tsolia M
    J Med Virol; 2021 Oct; 93(10):6040-6044. PubMed ID: 34156112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort.
    Landaas ET; Storm ML; Tollånes MC; Barlinn R; Kran AB; Bragstad K; Christensen A; Andreassen T
    J Clin Virol; 2021 Apr; 137():104789. PubMed ID: 33736946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting.
    Sood N; Shetgiri R; Rodriguez A; Jimenez D; Treminino S; Daflos A; Simon P
    PLoS One; 2021; 16(4):e0249710. PubMed ID: 33819311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19.
    Stokes W; Berenger BM; Portnoy D; Scott B; Szelewicki J; Singh T; Venner AA; Turnbull L; Pabbaraju K; Shokoples S; Wong AA; Gill K; Guttridge T; Proctor D; Hu J; Tipples G
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1721-1726. PubMed ID: 33742322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study.
    Winkel B; Schram E; Gremmels H; Debast S; Schuurman R; Wensing A; Bonten M; Goedhart E; Hofstra M;
    BMJ Open; 2021 Oct; 11(10):e048206. PubMed ID: 34645658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
    Boum Y; Fai KN; Nikolay B; Mboringong AB; Bebell LM; Ndifon M; Abbah A; Essaka R; Eteki L; Luquero F; Langendorf C; Mbarga NF; Essomba RG; Buri BD; Corine TM; Kameni BT; Mandeng N; Fanne M; Bisseck AZ; Ndongmo CB; Eyangoh S; Hamadou A; Ouamba JP; Koku MT; Njouom R; Claire OM; Esso L; Epée E; Mballa GAE
    Lancet Infect Dis; 2021 Aug; 21(8):1089-1096. PubMed ID: 33773618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity, and low cost.
    Matsuda EM; de Campos IB; de Oliveira IP; Colpas DR; Carmo AMDS; Brígido LFM
    J Med Virol; 2021 Jul; 93(7):4405-4410. PubMed ID: 33788270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing.
    Chiu RYT; Kojima N; Mosley GL; Cheng KK; Pereira DY; Brobeck M; Chan TL; Zee JS; Kittur H; Chung CYT; Tsang E; Maran K; Yung RW; Leung AC; Siu RH; Ng JP; Choi TH; Fung MW; Chan WS; Lam HY; Lee KH; Parkin S; Chao FC; Ho SK; Marshak DR; Ma ES; Klausner JD
    Microbiol Spectr; 2021 Sep; 9(1):e0034221. PubMed ID: 34346748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19.
    Fenollar F; Bouam A; Ballouche M; Fuster L; Prudent E; Colson P; Tissot-Dupont H; Million M; Drancourt M; Raoult D; Fournier PE
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139420
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs.
    Hartard C; Berger S; Josse T; Schvoerer E; Jeulin H
    Clin Chem Lab Med; 2021 Nov; 59(12):2003-2009. PubMed ID: 34331847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples.
    Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B
    PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.